Fifteen Years of Immunological Follow-up of Women Who Received One, Two and Three Doses of the Bivalent HPV Vaccine in the CVT (Costa Rican HPV-16 18 Vaccine Trial) or the CVT EXTEND Study
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 16 Nov 2017
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary)
- Indications Cervical cancer; Human papillomavirus infections
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms CVT EXTEND
- 08 Nov 2017 Planned initiation date changed from 1 Nov 2017 to 17 Nov 2017.
- 26 Oct 2017 Planned initiation date changed from 31 Oct 2017 to 1 Nov 2017.
- 24 Oct 2017 Planned initiation date changed from 20 Oct 2017 to 31 Oct 2017.